Correlation between the extraversion and occurrence rate of eye contact in the post-evaluation. by Atsushi Nakazawa (15892700)

Optimal latency <i>τ</i>* as a function of discount factor <i>γ</i> and cost <i>a</i>. by Kevin Lloyd (839940)

“…<p>The optimal latency <i>τ</i>* tends to decrease as either the discount factor <i>γ</i> or the cost of acting quickly <i>a</i> decrease. …”

Total and <i>H</i>. <i>felis</i>-specific immunoglobulin levels in infected and uninfected mice. by Jennifer Gossmann (3181209)

“…<i>felis</i>-specific immunoglobulin levels were decreased in infected <i>Plcg2</i>^{<i>Ali5/+</i>} mice. …”

IS ETHANOL STABILITY OF MILK A RELIABLE TEST? by Rafael Fagnani (4679620)

“…Unstable milk to ethanol has pH values ranging between 6.6-6.8 with low microbiological count (less than 105 cell.mL-1) and higher lactose percentages (up to 4.5%). As bacterial count increase, the lactose percent tends to decrease, but not necessarily together. …”

RSV A2 replication in the ovine model. by Thomas Démoulins (517537)

“…After the initial decrease of RSV A2 titers, a second peak was detected in 5 out of 6 animals, showing the capacity of RSV A2 to replicate <i>in vivo</i> in the ovine model.…”

Construction and calibration of a bar weighing lysimeter by Daiane de Cinque Mariano (10413858)

“…Calibration of each lysimeter was performed after field installation. The results showed a linear response (R2 > 0.9999) of electric signal (mV) to mass increase or decrease (kg) with minimum hysteresis. …”

Comparison of Na⁺ current recordings in control cultures compared with cultures treated with FUdR or AraC prepared from P0-2 rat pups. by Heiko M. Lesslich (12219026)

Sampling site overview and data analysis workflow. by Ilona Urbarova (6197741)

Metabolites and gut microbial products. by Ditte Olsen Lützhøft (10837857)

Image3_A distinct immune landscape in anti-synthetase syndrome profiled by a single-cell genomic study.jpeg by Jiayu Ding (12005975)

“…As ASS and MDA5⁺ DM have similar organ involvements, MDA5⁺ DM was used as a disease control. …”

Table1_A distinct immune landscape in anti-synthetase syndrome profiled by a single-cell genomic study.docx by Jiayu Ding (12005975)

“…As ASS and MDA5⁺ DM have similar organ involvements, MDA5⁺ DM was used as a disease control. …”

Image1_A distinct immune landscape in anti-synthetase syndrome profiled by a single-cell genomic study.jpeg by Jiayu Ding (12005975)

“…As ASS and MDA5⁺ DM have similar organ involvements, MDA5⁺ DM was used as a disease control. …”

Image2_A distinct immune landscape in anti-synthetase syndrome profiled by a single-cell genomic study.jpeg by Jiayu Ding (12005975)

“…As ASS and MDA5⁺ DM have similar organ involvements, MDA5⁺ DM was used as a disease control. …”

Table2_A distinct immune landscape in anti-synthetase syndrome profiled by a single-cell genomic study.docx by Jiayu Ding (12005975)

“…As ASS and MDA5⁺ DM have similar organ involvements, MDA5⁺ DM was used as a disease control. …”

Image4_A distinct immune landscape in anti-synthetase syndrome profiled by a single-cell genomic study.jpeg by Jiayu Ding (12005975)

“…As ASS and MDA5⁺ DM have similar organ involvements, MDA5⁺ DM was used as a disease control. …”

Image6_A distinct immune landscape in anti-synthetase syndrome profiled by a single-cell genomic study.jpeg by Jiayu Ding (12005975)

“…As ASS and MDA5⁺ DM have similar organ involvements, MDA5⁺ DM was used as a disease control. …”

Recognition of <i>F. novicida</i> strains by the mitochondria and Golgi complex in THP-1 cells. by Dhandy Koesoemo Wardhana (21956781)

Recognition of <i>F. novicida</i> strains by lysophagosomes and lysosomes in THP-1 cells. by Dhandy Koesoemo Wardhana (21956781)

P-α-syn expression in the appendix/cecum across species. by Alexandra D. Zinnen (8259906)

Effects of a person-centred telephone-support in patients with chronic obstructive pulmonary disease and/or chronic heart failure – A randomized controlled trial by Andreas Fors (5706587)

“…</p><p>Results</p><p>At six-month follow-up no difference in the composite score was found between the two study groups (57.6%, n = 68 vs. 46.6%, n = 48; OR = 1.6, 95% CI: 0.9–2.7; P = 0.102) in the intention-to-treat analysis (n = 221); however, significantly more patients in the control group showed a clinically important decrease in GSE (≥ 5 units) (22.9%, n = 27 vs. 9.7%, n = 10; OR = 2.8, 95% CI: 1.3–6.0; P = 0.011). …”